CA2639976A1 - Application directe de reactifs de reticulation non toxiques pour resister a la deformation progressive de la colonne vertebrale - Google Patents

Application directe de reactifs de reticulation non toxiques pour resister a la deformation progressive de la colonne vertebrale Download PDF

Info

Publication number
CA2639976A1
CA2639976A1 CA002639976A CA2639976A CA2639976A1 CA 2639976 A1 CA2639976 A1 CA 2639976A1 CA 002639976 A CA002639976 A CA 002639976A CA 2639976 A CA2639976 A CA 2639976A CA 2639976 A1 CA2639976 A1 CA 2639976A1
Authority
CA
Canada
Prior art keywords
crosslinking reagent
disc
increasing
tissue
crosslinking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002639976A
Other languages
English (en)
Inventor
Tom Hedman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2639976A1 publication Critical patent/CA2639976A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Surgical Instruments (AREA)
CA002639976A 2006-02-02 2006-02-02 Application directe de reactifs de reticulation non toxiques pour resister a la deformation progressive de la colonne vertebrale Abandoned CA2639976A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/003636 WO2007089233A1 (fr) 2006-02-02 2006-02-02 Application directe de réactifs de réticulation non toxiques pour résister à la déformation progressive de la colonne vertébrale

Publications (1)

Publication Number Publication Date
CA2639976A1 true CA2639976A1 (fr) 2007-08-09

Family

ID=38327701

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002639976A Abandoned CA2639976A1 (fr) 2006-02-02 2006-02-02 Application directe de reactifs de reticulation non toxiques pour resister a la deformation progressive de la colonne vertebrale

Country Status (4)

Country Link
EP (1) EP1993497A4 (fr)
JP (1) JP2009525327A (fr)
CA (1) CA2639976A1 (fr)
WO (1) WO2007089233A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070202143A1 (en) * 2001-08-31 2007-08-30 Hedman Thomas P Direct application of non-toxic crosslinking reagents to restabilize surgically destabilized intervertebral joints
US8241654B2 (en) * 2008-09-26 2012-08-14 Tyco Healthcare Group Lp Reactive surgical implant
ITRM20090360A1 (it) * 2009-07-13 2011-01-14 Antonio Zuorro Preparato antimicrobico per uso topico a base di metilgliossale
CN110842644B (zh) * 2019-11-09 2021-02-02 北京工业大学 一种基于数控负载信息的机床运动部件接触刚度退化率监测方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270446A (en) * 1989-04-04 1993-12-14 Suntory Limited Decolorized crosslinked products and method for decolorization of crosslinked products
CN1113672C (zh) * 1996-11-05 2003-07-09 嘉年生化产品有限公司 用京尼平对生物医学材料进行化学改性
CA2536415C (fr) * 2001-08-31 2013-07-23 University Of Southern California Reactifs de reticulation destines a traiter des troubles des disques intervertebraux
US7435722B2 (en) * 2001-08-31 2008-10-14 University Of Southern California Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability
US9084772B2 (en) * 2001-08-31 2015-07-21 Orthopeutics L.P. Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues
IL162419A0 (en) * 2001-12-10 2005-11-20 Colbar Lifescience Ltd Methods, devices, and preparations for intervertebral disc treatment
US20050209699A1 (en) * 2002-03-19 2005-09-22 Slivka Michael A Method for nonsurgical treatment of the nucleus pulposus of the intervertebral disc using genipin or proanthrocyanidin, and kit therefor
US6812211B2 (en) * 2002-03-19 2004-11-02 Michael Andrew Slivka Method for nonsurgical treatment of the intervertebral disc and kit therefor

Also Published As

Publication number Publication date
WO2007089233A8 (fr) 2008-10-16
EP1993497A4 (fr) 2011-11-09
WO2007089233A1 (fr) 2007-08-09
EP1993497A1 (fr) 2008-11-26
JP2009525327A (ja) 2009-07-09

Similar Documents

Publication Publication Date Title
US8153600B2 (en) Direct application of non-toxic crosslinking reagents to resist progressive spinal deformity
US8211938B2 (en) Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity
US8119599B2 (en) Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity
US8450276B2 (en) Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability
US7435722B2 (en) Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability
US9084772B2 (en) Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues
US20100040593A1 (en) Formulations for nonsurgical exogenous crosslink therapy
EP2448568B1 (fr) Formulation améliorée pour thérapie de réticulation exogène non chirurgicale
AU2002335683A1 (en) Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues
US8198248B2 (en) Formulations for nonsurgical exogenous crosslink therapy
EP2139495A1 (fr) Application directe de réactifs de réticulation non toxiques pour restabiliser des joints intervertébraux déstabilisés par une opération chirurgicale
US20080260712A1 (en) Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability
CA2639976A1 (fr) Application directe de reactifs de reticulation non toxiques pour resister a la deformation progressive de la colonne vertebrale
KR101238647B1 (ko) 추간판 장애의 치료를 위한 교차결합제

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20131213